home / stock / bctx / bctx news

BCTX News and Press, BriaCell Therapeutics Corp. From 06/17/21

Stock Information
Company Name: BriaCell Therapeutics Corp.
Stock Symbol: BCTX
Market: NASDAQ
Website: briacell.com
Menu
BCTX BCTX Quote BCTX Short BCTX News BCTX Articles BCTX Message Board
Get BCTX Alerts

News, Short Squeeze, Breakout and More Instantly...
BCTX - Midatech Pharma, Cellect Biotechnology leads healthcare gainers; CureVac, Novan among major losers

Gainers: Midatech Pharma (MTP) +37%, Cellect Biotechnology (APOP) +30%, Synaptogenix (SNPX) +24%, Clearside Biomedical (CLSD) +16%, Tiziana Life Sciences (TLSA) +16%.Losers: CureVac (CVAC) -44%, Novan (NOVN) -19%, Prothena (PRTA) -14...
BCTX - CureVac, Hecla Mining among premarket losers' pack

CureVac (CVAC) -47% as Bill Gates-backed biotech shows below-par efficacy for COVID-19 vaccine candidate.Gaucho Group (VINO) -20%.Creatd (CRTD) -17% after proposing stock offeringNovan (NOVN) -14% after proposing capital raise.Torchlight Energy Resources (TRCH)&#...

BCTX - Opthea, Kindred Biosciences leads healthcare gainers; Inhibikase Therapeutics, Paratek Pharmaceuticals among major losers

Gainers: Opthea (OPT) +47%, Kindred Biosciences (KIN) +45%, Aprea Therapeutics (APRE) +38%, Altimmune (ALT) +21%, BriaCell Therapeutics (BCTX) +15%.Losers: Inhibikase Therapeutics (IKT) -24%, Paratek Pharmaceuticals (PRTK) -14%,...

BCTX - BriaCell stock soars 10% after expanding breast cancer technology into multiple indications

BriaCell Therapeutics (BCTX) jumps 10% premarket after announcing the advancement of its targeted oncology therapeutics into several novel immunotherapy cell lines: Bria-Pros for prostate cancer, Bria-Mel for melanoma, and Bria-Lung for lung cancer.BriaCell’s immunotherapy tr...
BCTX - BriaCell Therapeutics Expands Breast Cancer Platform Technology into Prostate, Melanoma, and Lung Cancers

BriaCell is expanding its breast cancer platform technology into other cancers including prostate, melanoma, and non-small cell lung cancer. Bria-OTS™, an off-the-shelf personalized immunotherapy for advanced breast cancer, remains on track to enter the clinic in 20...

BCTX - BriaCell Therapeutics receives proceed of $12.88M from warrant exercises

BriaCell Therapeutics (BCTX) has received $12.88M in proceeds from investors exercising 2,425,300 common share purchase warrants an exercise price of $5.3125/ share.The Warrants were issued as part of the units sold in ccompany’s public offering that closed on February 26, 2021.Company...

BCTX - BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises

BERKELEY, Calif. and VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies ...
BCTX - BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET

BERKELEY, Calif. and VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...

BCTX - BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement

BERKELEY, Calif. and VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW)(TSX-V:BCT) (the "Company" or “BriaCell”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast c...

BCTX - SENS, ADMP, LPTH and NGL among midday movers

Gainers: SemiLEDs (LEDS) +66%.Senseonics (SENS) +49%.Windtree Therapeutics (WINT) +38%.MoSys (MOSY) +34%.Ra Medical Systems (RMED) +29%.LightPath Technologies (LPTH) +27%.American Superconductor (AMSC) +26%.Smart Sand (SND) +25%.The9 (NCTY) +24%.Vinco Ventures (BBIG) +22%....
Previous 10 Next 10